Cancer incidence and mortality after heart transplantation – A population-based national cohort study

References

• Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report—2018; focus theme: multiorgan transplantation. J Heart Lung Trans. 2018;37:1155–1168.
   PubMed Web of Science ®Google Scholar
• ISHLT Adult Heart Transplantation Statistics. 2018. [cited 2018 Dec 4]. Available from: https://ishltregistries.org/registries/slides.asp.
   Google Scholar
• Youn J, Stehlik J, Wilk AR, et al. Temporal trends of de novo malignancy development after heart transplantation. J Am Coll Cardiol. 2018;71:40–49.
   PubMed Web of Science ®Google Scholar
• Åberg F, Pukkala E, Höckerstedt K, et al. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Trans. 2008;14:1428–1436.
   PubMed Web of Science ®Google Scholar
• Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89:1221–1227.
   PubMed Web of Science ®Google Scholar
• Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients. Jama. 2011;306:1891–1901.
   PubMed Web of Science ®Google Scholar
• Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int. 2000;13:394.
   PubMedGoogle Scholar
• Hall EC, Pfeiffer RM, Segev DL, et al. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013;119:2300–2308.
   PubMed Web of Science ®Google Scholar
• Doesch AO, Müller S, Konstandin M, et al. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. Transplant Proc. 2010;42:3694–3699.
   PubMed Web of Science ®Google Scholar
• Crespo-Leiro MG, Alonso-Pulpón L, Vázquez de Prada JA, et al. Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant. 2008;8:1031–1039.
   PubMed Web of Science ®Google Scholar
• Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80:254.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125:1747–1754.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic cancer registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–455.
   PubMed Web of Science ®Google Scholar
• Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Trans. 2010;10:1889–1896.
   PubMed Web of Science ®Google Scholar
• Higgins RS, Brown RN, Chang PP, et al. A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population. J Heart Lung Trans. 2014;33:478–485.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Villeneuve PJ, Wielgosz A, et al. The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Trans. 2010;10:637–645.
   PubMed Web of Science ®Google Scholar
• Acuna SA, Fernandes KA, Daly C, et al. Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. JAMA Oncol. 2016;2:463–469.
   PubMed Web of Science ®Google Scholar
• Na R, Grulich AE, Meagher NS, et al. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am J Trans. 2013;13:1296–1304.
   PubMed Web of Science ®Google Scholar
• Na R, Grulich AE, Meagher NS, et al. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Trans. 2013;13:174–183.
   PubMed Web of Science ®Google Scholar
• Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008 - a Swedish population-based study. Int J Cancer. 2013;132:1429–1438.
   PubMed Web of Science ®Google Scholar
• Finnish Cancer Registry - Cancer statistics. 2016. [cited 2018 Dec 4]. Available from: https://cancerregistry.fi/statistics/.
   Google Scholar
• Öhman J, Rexius H, Mjörnstedt L, et al. Oral and lip cancer in solid organ transplant patients – A cohort study from a Swedish Transplant Centre. Oral Oncol. 2015;51:146–150.
   PubMed Web of Science ®Google Scholar
• Fernberg P, Edgren G, Adami J, et al. Time trends in risk and risk determinants of non-hodgkin lymphoma in solid organ transplant recipients. Am J Trans. 2011;11:2472–2482.
   PubMed Web of Science ®Google Scholar
• Jensen AO, Svaerke C, Farkas D, et al. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol. 2010;90:474–479.
   PubMed Web of Science ®Google Scholar
• Rodriguez Cetina Biefer H, Sündermann SH, Emmert MY, et al. Surviving 20 years after heart transplantation: a success story. Ann Thorac Surg. 2014;97:499–504.
   PubMed Web of Science ®Google Scholar
• Roussel JC, Baron O, Périgaud C, et al. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality. J Heart Lung Trans. 2008;27:486–493.
   PubMed Web of Science ®Google Scholar
• Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–1131.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma. Jco. 2015;33:3235–3242.
   PubMed Web of Science ®Google Scholar
• Sherston SN, Carroll RP, Harden PN, et al. Predictors of cancer risk in the long-term solid-organ transplant recipient. Transplantation. 2014;97:605–611.
   PubMed Web of Science ®Google Scholar
• Madeleine MM, Carter JJ, Johnson LG, et al. Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer Med. 2014;3:1440–1447.
   PubMed Web of Science ®Google Scholar
• Tufaro AP, Azoury SC, Crompton JG, et al. Rising incidence and aggressive nature of cutaneous malignancies after transplantation: An update on epidemiology, risk factors, management and surveillance. Surg Oncol. 2015;24:345–352.
   PubMed Web of Science ®Google Scholar
• Penn I, Hammond W, Brettschneider L, et al. Malignant lymphomas in transplantation patients. Transplant Proc. 1969;1:106–112.
   PubMed Web of Science ®Google Scholar
• Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Trans. 2004;4:222–230.
   PubMed Web of Science ®Google Scholar
• El-Hamamsy I, Stevens L, Carrier M, et al. Incidence and prognosis of cancer following heart transplantation using RATG induction therapy. Transplant Int. 2005;18:1280–1285.
   PubMed Web of Science ®Google Scholar
• Crespo-Leiro MG, Delgado-Jiménez J, López L, et al. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014;28:1142–1147.
   PubMed Web of Science ®Google Scholar
• Kumarasinghe G, Lavee O, Parker A, et al. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors. J Heart Lung Trans. 2015;34:1406–1414.
   PubMed Web of Science ®Google Scholar